This conclusion was confirmed by the absence of significant differences in ACE2 mRNA expression after further inhibition of ADAM17 expression, which reduced ACE2 expression and activity in cardiomyocytes in vitro and in vivo after ADAM17 inhibition, reduced myocardial remodeling after MI, and improved prognosis. Here, ADAM17 is linked to myocardial infarction.